Tuesday, November 19, 2024

Medical Cannabis News

Health Europa brings you the latest Medical Cannabis News from across the field of European Healthcare & Social Care Policy.

Boosting mental health: patent filed for Omega-3 and CBD formulation

Boosting mental health: patent filed for Omega-3 and CBD formulation

CanaQuest has filed a provisional Omega-3 and CBD formulation patent which aims to help address mental health. CanaQuest, a company developing unique health products and...
Evidence CBD may reduce cytokine storm and inflammation in COVID-19

Evidence CBD may reduce cytokine storm and inflammation in COVID-19

A new study has revealed early evidence that CBD may help to reduce cytokine storms and excessive lung inflammation in patients with COVID-19. Carried out...
Colombian cannabis producer Clever Leaves granted EU GMP certification

Colombian cannabis producer Clever Leaves granted EU GMP certification

Clever Leaves’ Colombian operation is the first medical cannabis facility to receive EU GMP certification in Latin America. Colombian cannabis producer, Clever Leaves, a multi-national...
Cannabis production as extraction and distillation technologies advance

Cannabis production as extraction and distillation technologies advance

MCN explores the evolution of cannabis production as extraction and distillation technologies advance. As the cannabis industry has blossomed and research and development in the...
A deep dive into Drug Science’s Project Twenty21

A deep dive into Drug Science’s Project Twenty21

Clinical Director Dr Chloe Sakal and Project Director Amelia Middlemiss give an update on the progress of Drug Science’s groundbreakingly ambitious Project Twenty21 programme. On...
Exploring Canada’s cannabis sector

Exploring Canada’s cannabis sector

MCN speaks with industry expert Jamie Shaw about cannabis sector regulation in Canada, the issues patients still encounter, and industry sexism. Jamie Shaw is a...
The evolution of cannabis in the US

The evolution of cannabis in the US

As the National Cannabis Industry Association celebrates its 10th anniversary, CEO Aaron Smith tells MCN about the evolution of cannabis in the US. Aaron Smith...
Court hearing to decide if NHS will cover cost of cannabis medication

Court hearing to decide if NHS will cover cost of cannabis medication

A landmark court hearing is set to decide whether the NHS should cover the cost of a patient’s cannabis medicine. Charlotte Caldwell, whose son Billy...
Medical cannabis research and policy in Israel

Medical cannabis research and policy in Israel

Yuval Landschaft, Director of the Israeli Medical Cannabis Agency, outlines Israel’s regulatory approach to cannabis-based medical treatment. In recent years, there has been an increase...
Cannabis research, innovation, and policy in Australia

Cannabis research, innovation, and policy in Australia

Professor Jennifer Martin, Chair of Clinical Pharmacology at the University of Newcastle and Director of the Australia Centre for Cannabinoid Clinical and Research Excellence,...
Cannabis culture: a Latin American perspective

Cannabis culture: a Latin American perspective

Writer and entrepreneur Simon Espinosa tells MCN about cannabis culture and the future of the industry in Latin America. Trilingual writer and entrepreneur Simon Espinosa...
The Center for Medicinal Cannabis Research with Dr Igor Grant

The Center for Medicinal Cannabis Research with Dr Igor Grant

In this article, Dr Igor Grant explores the work of the Center for Medicinal Cannabis Research. When the Center for Medicinal Cannabis Research at UC...
‘A national disgrace’: call to improve medical cannabis access in the UK

‘A national disgrace’: call to improve medical cannabis access in the UK

A campaigner has urged the UK government to improve access to medical cannabis prescriptions as restrictive guidance from NICE and the BPNA has meant...
“Come out firing”: Australia's cannabis industry growth continues

“Come out firing”: Australian cannabis growth continues

With Australia’s cannabis industry growing exponentially, could legislation become more progressive? With Australia’s cannabis economy growing exponentially following the country’s 2016 move to permit the...
What happened to cannabis stocks?

What happened to cannabis stocks?

MCN examines the factors affecting the falling value of cannabis stocks and investigates whether investing in the industry is worth the risk in 2020. Investors...
Cannabis law and policy in Gibraltar

Cannabis law and policy in Gibraltar

Hassans International Law Firm Limited Partner Aaron Payas, CFA gives MCN an overview of Gibraltar’s cannabis landscape. In October 2019, the government of Gibraltar approved...
CLEAR UK: lobbying, policy, and the flaws of CBD Novel Foods regulation

CLEAR UK: lobbying, policy, and the flaws of CBD Novel Foods regulation

CLEAR Cannabis Law Reform President Peter Reynolds speaks to MCN about lobbying, policy and the flaws of CBD Novel Foods regulation. CLEAR Cannabis Law Reform,...
Cannabis medicine, education, and policy in Switzerland

Cannabis medicine, education, and policy in Switzerland

Professor Rudolf Brenneisen of the Swiss Society of Cannabis in Medicine tells us about medical cannabis in Switzerland. The Swiss Society of Cannabis in Medicine...
Medical cannabis in North Macedonia

Medical cannabis in North Macedonia

Kostadin Dukovski, President of North Macedonia’s Association of Medical Cannabis Cultivators, tells MCN about Macedonian policy, economy and future developments. The Association of Medical Cannabis...
Education and regulation for the EU cannabis market

Education and regulation for the EU cannabis market

James O’Dowd, Secretary General of the European Alliance for Medicinal Cannabis, talks cannabis policy and oversight in the EU cannabis market. The European Alliance for...

Featured Special Reports

Pin It on Pinterest